Atrial fibrillation Trials in Witten, Germany
Conditions / Atrial fibrillation / Witten, Germany
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT00808067 | RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial | COMPLETED | PHASE3 |
| NCT00526136 | Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study | COMPLETED | PHASE2 |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |